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Abstract The arginine-specific reagent phenylglyoxal has been 
used to identify a hyper-reactive arginine residue which is essen- 
tial for activity in the type II dehydroquinases of Streptomyces 
coelicolor and Aspergillus nidulans. Electrospray mass spectrom- 
etry was used both to characterise the phenylglyoxal modified 
protein, and to identify the phenylglyoxal modified peptides fol- 
lowing enzymatic digestion. The advantages of using electrospray 
mass spectrometry for monitoring arginine medication aimed at 
identifying functional residues in proteins are discussed. 
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I. Introduction 
The type II dehydroquinases (3-dehydroquinate d hydra- 
tases, EC 4.2.1.10) catalyse the conversion of dehydroquinate 
to dehydroshikimate. This reaction, which occurs on both the 
biosynthetic shikimate pathway and the catabolic quinate path- 
way [1-3], involves the trans elimination of water [4]. Little is 
known about he structure and mechanism of the type II dehy- 
droquinases which are clearly mechanistically and structurally 
different from the better characterised type I enzymes [5,6]. The 
type I enzymes are exclusively biosynthetic [5], have a con- 
served active site lysine residue [7], and catalyse a cis elimina- 
tion via an imine intermediate [4,8] with the participation of a 
conserved histidine residue as the general base [9]. In contrast 
the fungal type II enzymes have an exclusively catabolic role 
[2,10] while the bacterial type II enzymes may be exclusively 
biosynthetic [11,12] or be involved in both biosynthesis and 
catabolism [13]. There is preliminary chemical modification 
evidence for a role for histidine in the type II enzymes [5], but 
there are no conserved lysine residues and this, together with 
the different stereochemistry and the failure of experiments o
inhibit he type II enzymes with substrate and sodium borohy- 
dride [5], emphasises their mechanistic distinction from the type 
I enzymes. 
A type II dehydroquinase has recently been crystallised [7] 
and to facilitate the structure determination wehave been using 
group specific chemical modification reagents to identify amino 
acid residues in the active site. Many enzymes which use car- 
boxylic acids as substrates utilise an arginine residue for car- 
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boxylate recognition [14] and in several cases the functional 
arginine has proved to be hyper-reactive [15]. The reagent phen- 
ylglyoxal (PGO) has been widely used to demonstrate he in- 
volvement of arginine residues in enzyme function [16,17]. 
However, the identification ofspecific arginine residues i  com- 
plicated by the relatively low stability of the adducts formed 
[17], their variable stoichiometry [17] and the necessity of using 
radiolabelled reagent. Also in the case of the type II dehydro- 
quinases the identification ofactive site residues i  further com- 
plicated by the relatively low affinity of the enzymes for both 
substrate and product and the lack of tight binding competitive 
inhibitors [5]. To determine whether an active site arginine was 
present a method was needed for analysing enzyme in the early 
stages of modification and correlating the modification of par- 
ticular residues directly with the loss of activity. We have used 
electrospray mass spectrometry to monitor the reaction of two 
type II dehydroquinases with PGO. This has permitted the 
simple characterisation of singly and multiply modified enzyme 
molecules and, through the direct analysis of enzymatic digests 
of the modified enzyme, the direct location of the modification 
sites without he necessity for sequencing or the use of radioac- 
tive or other labels. By this means we have identified a single 
hyper-reactive arginine residue that is essential for activity and 
is probably in the substrate binding site of the type II dehydro- 
quinases. 
2. Experimental 
The type II dehydroquinases from Streptomyces coelicolor [11] and 
Aspergillus nidulans [18] were overexpressed in Escherichia coli and 
assayed [5] and purified as described previously [19,18]. Protein concen- 
trations were determined spectrophotometrically at 280 nm using ex- 
tinction coefficients calculated from the amino acid compositions [20]. 
Enzyme samples in 100 mM sodium bicarbonate buffer, pH 9.4 were 
pre-incubated for5 min at 25°C and then PGO (freshly made up 50 mM 
stock solution in water) was added to a final concentration f 0.54.0 
mM. Aliquots were removed at various times for enzyme assay. En- 
zyme inactivated to different extents for mass pectrometry was pre- 
pared by stopping the reaction by gel filtration on a Sephadex G50 
column (200 mm × 17 mm, flow rate 15 ml-h -~) equilibrated with 10 
mM ammonium bicarbonate. To remove low molecular weight con- 
taminants prior to mass pectrometry he enzyme samples were washed 
twice by diluting 50-fold with HPLC grade water and reconcentrated 
using Centricon-10 centrifugal concentrators (Amicon, Stonehouse, 
Gloucestershire, UK). 
To prepare peptides from the native and modified enzyme protein 
samples were first denatured in6 M GnHCI for 15 rain and then diluted 
with 0.5% (w/v) ammonium bicarbonate oa GnHC1 concentration f 
1 M and incubated with 2% (w/w) chymotrypsin (stock solution 1 g/1 
chymotrypsin i 1 mM HC1) for 45 min at 25°C. The digestion was 
stopped by freezing the samples at -80°C. 
Mass spectrometry was performed on a VG Platform quadrupole 
mass spectrometer fitted with a pneumatically assisted electrospray 
(ionspray) source and controlled via the VG MassLynx software (VG 
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Fig. 1. Inactivation of the type II dehydroquinase of S. coelicolor by PGO. Semi-logarithmic plot of residual activity as a function of time. PGO 
concentrations 0.5 mM (v), 1.0 mM (A), 2.0 mM (A) and 4 mM (e). 
Biotech Ltd., Altrincham. Cheshire, UK). Carrier solvent [1:1 (v/v) 
acetonitrile/water, 0.2% formic acid] infusion was controlled at 10 Pl/ 
min using a Harvard syringe pump (Harvard Apparatus, South Natic, 1 00- 
MA, USA). Protein samples were dissolved in carrier solvent at a 
concentration f 20 pmol/pl, centrifuged at5000 x g for 2 min and then 
10-20 pl samples injected directly into the carrier stream. MaxEnt 
deconvolution [21] was applied for quantitative analysis of the raw data 
using a 1.0 Da peak width and 1 Da/channel resolution. 
The protein digests were separated by HPLC on a C- 18 reverse phase 
column (,uBondapak, Waters, Watford, Hertfordshire, UK) using 2% 
(v/v) acetonitrile in 0.1% (v/v) trifluoracetic acid as the initial solvent 
(flow rate 0.5 ml/min); after an 8 min wash to remove GdnHC1 a linear 
gradient of ~70% acetonitrile (v/v) in 0.1% (v/v) trifluoracetic acid was 0 
applied to elute the peptides. The column eluant was introduced irectly 
into the mass spectrometer with a drying gas flow of 400 1. h -~ and the 100 
source temperature s t at 100°C. The absorption profile of the eluted 
peptides was recorded at 214 nm and centroid mass spectra in the range 
400-1800 amu were recorded at 4 s intervals. 
3. Results and discussion 
The inactivation of the S. coelicolor type II dehydroquinase 
with PGO followed pseudo first order kinetics (Fig. 1). A sec- 0 
ondary plot of the observed pseudo first order rate constants 
against PGO concentration was linear (data not shown) and 100 
gave a second order inactivation rate constant of 89 M- ' .  min -'. 
Similar results were obtained for inactivation of the A. nidulans 
enzyme by PGO; in this case the second order rate constant was 
150 M -1. min -1. These observations suggested that arginine res- 
idue(s) were required for the type II dehydroquinase r action. 
The relationship between the extent of inactivation and the 
number of arginine residues modified by PGO was monitored 
by mass spectrometry; the spectra observed for three samples 0 
inactivated to different extents are shown in Fig. 2. During the 
early stages of inactivation (exemplified by 15% inactivation) 
the major peak was of unmodified enzyme and the only signif- 
icant modified species had a mass difference of +116 
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Fig. 2. Electrospray mass spectra of samples of the type II dehydroqui- 
nase of S. coelicolor modified to different extents with PGO: (a) 15% 
inactivated, (b) 60% inactivated and (c) 95% inactivated. 
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Fig. 3. Structures of adducts formed by the reaction of PGO with arginine residues. 
(Mr = 16,666) (Fig. 2). This mass difference corresponds to the 
incorporation of one PGO per site with the loss of water (see 
Fig. 3). For low extents of inactivation there was a good corre- 
lation between the extent of inactivation and the relative size 
of this +116 peak (Table 1). In the sample that was 60% inac- 
tivated the two major peaks due to the +116 species and to 
unmodified protein together accounted for 80% of the material 
(Fig. 2). These data suggest hat the initial inactivation of the 
enzyme is due to the formation of a simple 1 : 1 adduct with 
PGO followed by dehydration. A number of minor modified 
species were also present including one with a mass difference 
of + 250 (Mr = 16,800), corresponding to the Takahashi adduct 
with two PGO's per arginine (see Fig. 3), and another with a 
mass difference of +232 (M r = 16,782) corresponding to two 
different arginines, each modified with a single phenylglyoxal. 
These minor peaks were more significant in 95% inactivated 
enzyme (Fig. 2); in this sample very little unmodified protein 
remained, the singly modified + 116 species was the most prom- 
inent peak and there were also small peaks due to multiply 
modified species and to Takahashi adducts for example at 
+232, +250, +366 (250 plus 116), +482 (250 plus 116 plus 
116) and at +500 (250 plus 250). 
To identify the primary site of modification samples of 
S. coelicolor dehydroquinase, modified to different extents with 
PGO, were digested with chymotrypsin and the peptides epa- 
rated and analysed by reverse phase chromatography/electro- 
spray mass spectrometry. In the 15% inactivated sample there 
was a single modified peptide of mass 3219 which corresponds 
to residues 1~8 of the enzyme + 116 mass units. This peptide 
contains 2 arginine residues (R2 and R23). When the currently 
available type II dehydroquinase quences are aligned to give 
best homology there is no conserved arginine that corresponds 
to R2 in the S. coelicolor enzyme. However, there is a totally 
conserved arginine that corresponds to R23 of the S. coelicolor 
Table 1 
Relative amounts of the adducts formed between PGO and the type II dehydroquinases. Samples were inactivated by treatment with PGO for various 
times, assayed for residual enzyme activity and then analysed by electrospray mass spectrometry (see Experimental section). 
Enzyme source % inactivation Relative percentages of adducts 
Native + 116 +232 +250 +366 +482 +500 
S. coelicolor 
A. nidulans 
15 77 23 . . . .  
60 44 35 10 11 - - 
95 2 31 19 21 18 4 5 
10 82 18 - - 
30 66 34 - - 
90 16 58 14 12 
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enzyme. This is R19 of the A. nidulans enzyme. It therefore 
seemed likely that R23 was the site of initial modification i  the 
S. coelicolor enzyme. Consistent with this observation A. nidu- 
lans enzyme modified in a similar way was found to contain a 
peptide of mass 2852 which corresponds to residues 1-24 of the 
enzyme plus 116 mass units; this peptide contains the single 
arginine residue R19 which corresponds to R23 in the S. coeli- 
color enzyme. 
In samples of 80% inactivated S. coelicolor enzyme the singly 
modified peptide 1-24 was found and, in addition, singly mod- 
ified peptides corresponding to residues 84-116 (Rl13) and 
139-156 (R144 and R155) were also observed. At this extent 
of modification it was not possible to detect any peptides con- 
taining the Takahashi adduct. The A. nidulans enzyme contains 
no arginine residues corresponding to R144 and R155. It does 
contain a residue corresponding to R113 but even at 95% inac- 
tivation no modification at this site was observed. The type II 
dehydroquinases contain an additional conserved arginine res- 
idue (R117 in the S. coelicolor enzyme). No evidence that this 
residue is modified by PGO has been obtained, but it should 
be noted that peptides containing this residue have proved 
difficult to detect by mass spectrometry. 
These results suggests that the conserved residue R23 in the 
S. coelicolor enzyme (R19 in the A. nidulans enzyme) is essential 
for enzyme function. This arginine is clearly hyper-reactive and 
on this basis is very likely to be involved in binding the carbox- 
ylate group of the substrate as has been shown for hyper- 
reactive arginine residues found at the carboxylate binding sites 
of other enzymes [15]. Much of the earlier work on arginine 
modification of enzymes with PGO has assumed that the major 
initial reaction involved the formation of the 2:1 Takahashi 
adduct [17] and the extent of modifcation was usually estimated 
by monitoring the incorporation of radioactive PGO and as- 
suming this 2: 1 stoichiometry. Our results how that the initial 
PGO modification of the type II dehydroquinases does not 
involve formation of the 2:1 Takahashi adduct but instead a 
1 : 1 adduct forms which is then very rapidly dehydrated (Fig. 
3). Our observations also confirm that the adducts formed 
between PGO and proteins are sufficiently stable to be analysed 
by the standard conditions used for the electrospray mass spec- 
trometry of proteins. A major difficulty in locating the sites of 
PGO modification has been the poor stability of the PGO 
modified peptides during purification, especially during reverse 
phase hplc in the presence of 0.1% acid. Although, under the 
conditions we describe there is undoubtedly significant hydrol- 
ysis of the PGO peptide adducts, the high sensitivity of electros- 
pray mass spectrometry permits the simple and rapid identifica- 
tion of the major sites of arginine modification in proteins. 
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